» Articles » PMID: 8886424

Analogues of Diverse Structure Are Unable to Differentiate Native Melatonin Receptors in the Chicken Retina, Sheep Pars Tuberalis and Xenopus Melanophores

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1996 Sep 1
PMID 8886424
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

1. The pineal hormone melatonin exerts its biological effects through specific, high affinity G-protein coupled receptors. Recently, three melatonin receptor subtypes (Mel1a, Mel1b and Mel1c) have been cloned. Neither the cloned subtypes, nor the native receptors have yet been compared in a detailed pharmacological analysis. 2. The present study examined the structure-activity relationships of a series of 21 melatonin analogues, by comparing their potency on the pigment aggregation response in Xenopus laevis melanophores with their affinity in radioligand binding competition studies in chicken retina and sheep pars tuberalis (PT), two tissues in which melatonin is known to mediate a biological response. 3. All but four of the analogues were full melatonin receptor agonists producing a concentration-related redistribution of pigment granules in cultured Xenopus melanophores. The remaining analogues produced little pigment aggregation at 10 microM. 4. Saturation studies with 2-[125I]-iodomelatonin identified a single binding site in the chicken retina and sheep PT membranes, with a KD of 36.6 +/- 2.8 and 37.3 +/- 4.3 pM, and a maximal number of binding sites (Bmax) of 16.6 +/- 0.5, and 40.1 +/- 1.7 fmol mg-1 protein, respectively. 5. Comparison of the potency/affinity of the analogues for the binding sites gave a highly significant correlation in each case, retina/melanophore, r = 0.97 (P < 0.001, n = 17), PT/melanophore, r = 0.97 (P < 0.001, n = 17) and PT/retina, r = 0.98 (P < 0.001, n = 21). 6. Despite their large range in affinity and structural diversity these melatonin agonists were unable to distinguish between melatonin receptors in the chicken retina, sheep pars tuberalis and Xenopus melanophores.

Citing Articles

Characterization of the Mel1c melatoninergic receptor in platypus (Ornithorhynchus anatinus).

Gautier C, Guenin S, Riest-Fery I, Perry T, Legros C, Nosjean O PLoS One. 2018; 13(3):e0191904.

PMID: 29529033 PMC: 5846726. DOI: 10.1371/journal.pone.0191904.


The putative melatonin receptor antagonist GR128107 is a partial agonist on Xenopus laevis melanophores.

Teh M, Sugden D Br J Pharmacol. 1999; 126(5):1237-45.

PMID: 10205014 PMC: 1565880. DOI: 10.1038/sj.bjp.0702404.

References
1.
Sugden D, Davies D, Garratt P, Jones R, Vonhoff S . Radioligand binding affinity and biological activity of the enantiomers of a chiral melatonin analogue. Eur J Pharmacol. 1995; 287(3):239-43. DOI: 10.1016/0014-2999(95)00489-0. View

2.
Garratt P, Travard S, Vonhoff S, Tsotinis A, Sugden D . Mapping the melatonin receptor. 4. Comparison of the binding affinities of a series of substituted phenylalkyl amides. J Med Chem. 1996; 39(9):1797-805. DOI: 10.1021/jm9508189. View

3.
Cheng Y, Prusoff W . Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973; 22(23):3099-108. DOI: 10.1016/0006-2952(73)90196-2. View

4.
Heward C, Hadley M . Structure-activity relationships of melatonin and related indoleamines. Life Sci. 1975; 17(7):1167-77. DOI: 10.1016/0024-3205(75)90340-9. View

5.
Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View